Sulotroban
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131652This classification denotes an antiplatelet agent with the molecular formula C16H17NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 74574CO5A6, chemically known as acetic acid, (4-(2-((phenylsulfonyl)amino)ethyl)phenoxy)- but generally known as sulotroban, which bears US NIH Compound Identifier 51550. European Medicines Agency schedules Sulotroban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10756MIG. The term SULOTROBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). SULOTROBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulotroban under HS 29350090 and SITC 51580. As of Q4 2014, SULOTROBAN remains the US FDA Preferred Term for this commodity. Sulotroban bears US NLM identifiers UMLS ID C0075621 and NCI Concept Code C84190. SMILES: S(=O)(=O)(NCCC1CCC(OCC(=O)O)CC1)C1CCCCC1.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.